CEL-SCI Corp. is a clinical-stage biotechnology company, which engages in the research, development, and manufacture of investigational immunotherapy products for the treatment of cancer and infectious diseases. Its product pipeline includes Multikine and Ligand Epitope Presentation System (LEAPS). Multikine is an investigational immunotherapy for the potential treatment of head and neck cancers. LEAPS is categorized into LEAPS-H1N1-DC, a product candidate for the treatment of pandemic influenza for hospitalized patients and CEL-2000 and CEL-4000, which are vaccine candidates for the treatment of rheumatoid arthritis. The company was founded by Maximilian de Clara on March 22, 1983 and is headquartered in Vienna, VA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Cel-Sci Corp.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Cel-Sci Corp. market cap is $79.45M.
What is the 52-week high for Cel-Sci Corp.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Cel-Sci Corp. 52 week high is $33.30 as of October 02, 2025.
What is the 52-week low for Cel-Sci Corp.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Cel-Sci Corp. 52 week low is $1.98 as of October 02, 2025.
What is Cel-Sci Corp. stock price today?
Cel-Sci Corp. stock price today is $10.18.
What was Cel-Sci Corp. stock price yesterday?
Cel-Sci Corp. stock price yesterday was $9.94.
What is the PE ratio of Cel-Sci Corp.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Cel-Sci Corp.’s P/E ratio is -1.01.
What is the Price-to-Book ratio of Cel-Sci Corp.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Cel-Sci Corp. P/B ratio is 7.5295.
What is the 50-day moving average of Cel-Sci Corp.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Cel-Sci Corp. 50-day moving average is $9.20.
